Company Announcement New Product License and Supply Agreement for US recreational cannabis market February 2, 2022February 2, 2022
Company Announcement Results for Phase I human clinical trial of CBD soft-gel product December 8, 2021December 8, 2021
Company Announcement Ethics Approval for CBD Topical Osteoarthritis Study October 21, 2021October 21, 2021
Company Announcement Dosing commences for Phase I human clinical trial October 4, 2021October 4, 2021
Company Announcement Enrolment commences for Phase I human clinical trial September 15, 2021September 15, 2021
